Clinical Trial Update: Lipopeptide Immunisation With GTU-multiHIV Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GTU-multiHIV lipopeptide immunisation in HIV-1 infection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GTU-multiHIV

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED